Flowserve Corp
NYSE:FLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Flowserve Corp
NYSE:FLS
|
US |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
LS Electric Co Ltd
KRX:010120
|
KR |
|
S
|
Swatch Group AG
BMV:UHRN
|
CH |
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
AU |
|
bluebird bio Inc
NASDAQ:BLUE
|
US |
|
F
|
Fresenius Medical Care AG
SWB:FMEA
|
DE |
|
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
|
US |
|
ACS Actividades de Construccion y Servicios SA
OTC:ACSAY
|
ES |
|
N
|
NK Lukoil PAO
F:LUK
|
RU |
Wall St Price Targets
FLS Price Targets Summary
Flowserve Corp
According to Wall Street analysts, the average 1-year price target for FLS is 90.17 USD with a low forecast of 73.17 USD and a high forecast of 105 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FLS's stock price target?
Price Target
90.17
USD
According to Wall Street analysts, the average 1-year price target for FLS is 90.17 USD with a low forecast of 73.17 USD and a high forecast of 105 USD.
What is the Revenue forecast for Flowserve Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 4 years is 5%.
What is the Operating Income forecast for Flowserve Corp?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 4 years is 15%.
What is the Net Income forecast for Flowserve Corp?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 4 years is 21%.
